Results 301 to 310 of about 407,965 (429)
Cardiopulmonary exercise testing as a prognosis‐assessing tool in heart failure with preserved ejection fraction
ESC Heart Failure, Volume 12, Issue 3, Page 2098-2106, June 2025.Abstract Aims
Patients with heart failure with preserved ejection fraction represent half of the heart failure patients nowadays, an at least steady trend due to the aging of the population. We investigated whether the parameters obtained from cardiopulmonary exercise testing (CPET) correlated with the prognosis of these patients.C. Rozados da Conceicao, A. Krannich, V. Zach, R. Pinto, A. Deichl, A. Feuerstein, L. Schleussner, F. Edelmann +7 morewiley +1 more sourceMortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
The Lancet, 2018 S. Head, M. Milojevic, J. Daemen, Jung‐Min Ahn, E. Boersma, E. H. Christiansen, M. Domanski, M. Farkouh, M. Flather, V. Fuster, M. Hlatky, N. Holm, W. Hueb, M. Kamalesh, Young-Hak Kim, T. Mäkikallio, F. Mohr, G. Papageorgiou, Seung‐Jung Park, Alfredo E. Rodríguez, J. Sabik, R. Stables, G. Stone, P. Serruys, A. Kappetein +24 moresemanticscholar +1 more sourceValidation of a biomarker‐based mortality score for cardiogenic shock patients: Comparison with a clinical risk score
ESC Heart Failure, Volume 12, Issue 3, Page 2157-2165, June 2025.Abstract Aims
Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials.Elina Hynninen, Heli Tolppanen, Mercedes Rivas‐Lasarte, Tuukka Tarvasmäki, Veli‐Pekka Harjola, Benjamin Deniau, Mari Hongisto, Ewa A. Jankowska, Raija Jurkko, Toni Jäntti, Anu Kataja, Alexandre Mebazaa, Tuija Sabell, Alessandro Sionis, Johan Lassus +14 morewiley +1 more sourceOCT vs Angiography for Guidance of Percutaneous Coronary Intervention of Calcified Lesions: The CALIPSO Randomized Clinical Trial.
JAMA CardiolAmabile N, Rangé G, Landolff Q, Bressollette E, Meneveau N, Lattuca B, Levesque S, Boueri Z, Adjedj J, Casassus F, Belfekih A, Veugeois A, Souteyrand G, Honton B. +13 moreeuropepmc +1 more sourcePrevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy
European heart journal. Acute cardiovascular care, 2018 M. Iannaccone, F. D’Ascenzo, P. Vadalà, S. Wilton, P. Noussan, F. Colombo, S. Raposeiras Roubín, E. Abu Assi, J. González-Juanatey, J. P. Simao Henriques, J. Saucedo, W. Kikkert, I. Nuñez-Gil, A. Ariza-Solé, Xiantao Song, D. Alexopoulos, C. Liebetrau, Tetsuma Kawaji, C. Moretti, R. Garbo, Z. Huczek, S. Nie, Toshiharu Fujii, L. Correia, M. Kawashiri, J. M. Garcia Acuña, D. Southern, Emilio Alfonso, B. Terol, A. Garay, Dongfeng Zhang, Yalei Chen, I. Xanthopoulou, N. Osman, H. Möllmann, H. Shiomi, F. Giordana, M. Kowara, K. Filipiak, Xiao Wang, Yan Yan, Jing-yao Fan, Y. Ikari, T. Nakahashi, K. Sakata, F. Gaita, M. Yamagishi, O. Kalpak, S. Kedev +48 moresemanticscholar +1 more source